The project contains raw and result files from a proteomic profiling of a male breast cancer (MBC) case. Label-free quantification-mass spectrometry (LFQ-MS) and bioinformatics analysis were employed to investigate the differentially expressed proteins (DEPs) among distinct tissue samples: the primary breast tumor, axillary metastatic lymph nodes and the adjacent non-tumor breast tissue. An additional proteomic comparative analysis was performed with a primary breast tumor of a female patient. A number of Ingenuity® Pathway Analysis (IPA) (QIAGEN Inc.) and functional annotation tools were used to further analyze the DEPs. Altogether, our findings revealed deregulated proteins into signaling pathways involved in the cancer development and provided a landscape of proteomic data for the MBC research.